NFL ends E.D. drug sponsorship

Share this article:
The NFL decided not to renew its sponsorship agreement with Levitra, which is co-marketed in the U.S. by Schering-Plough and GlaxoSmithKline. The league says it will not seek a replacement in the category, according to published reports. The NFL based its decision on the tone of ads for erectile dysfunction drugs. Over the past three years advertising has ranged in focus from men’s health to men’s performance and lifestyle. Ads by Levitra and others have recently been more restrained, however, not mentioning a product name but describing conditions the drug could help treat.
Share this article:
You must be a registered member of MMM to post a comment.

The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.

Email Newsletters